IHIsabelle Huvent

Isabelle Huvent

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Isabelle Huvent has a total of 177 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cyclophilin A allows the allosteric regulation of a structural motif in the disordered domain 2 of NS5A and thereby fine-tunes HCV RNA replication

    by Marie Dujardin, Vanesa Madan, Neha S. Gandhi, François-Xavier Cantrelle, Hélène Launay, Isabelle Huvent, Ralf Bartenschlager, Guy Lippens, Xavier Hanoulle


  • Open Access

    Major Differences between the Self-Assembly and Seeding Behavior of Heparin-Induced and in Vitro Phosphorylated Tau and Their Modulation by Potential Inhibitors

    by Clément Despres, Jing Di, François-Xavier Cantrelle, Zizheng Li, Isabelle Huvent, Béatrice Chambraud, Jing Zhao, Jianle Chen, Shiguo Chen, Guy Lippens, et al.

    Self-assembly of the microtubule-associated protein tau into neurotoxic oligomers, fibrils, and paired helical filaments, and cell-to-cell spreading of these pathological tau species are critical processes underlying the pathogenesis of Alzheimer’s disease (AD) and other tauopathies. Modulating the self-assembly process and inhibiting formation and spreading of such toxic species are promising strategies for therapy development. A challenge in investigating tau self-assembly in vitro is that unlike most amyloidogenic proteins, tau does not aggregate in the absence of posttranslational modifications (PTM), aggregation inducers, or pre-formed seeds. The most common induction method is addition of polyanions, such as heparin, yet this artificial system may not represent adequately tau self-assembly in vivo, which is driven by aberrant phosphorylation and other PTMs, potentially leading to in-vitro data that do not reflect the behavior of tau and its interaction with modulators in vivo. To tackle these challenges, methods for in-vitro phos-phorylation of tau to produce aggregation-competent forms recently have been introduced (Despres et al., Identifica-tion of the Tau phosphorylation pattern that drives its aggregation, Proc. Natl. Acad. Sci. USA, 2017). However, the oli-gomerization, seeding, and interaction with assembly modulators of the different forms of tau have not been studied to date. To address these knowledge gaps, we compared here side-by-side the self-assembly and seeding activity of heparin-induced tau with two forms of in-vitro phosphorylated tau and tested how the molecular tweezer CLR01, a negatively charged compound, affected these processes. Tau was phosphorylated by incubation either with activated extracellular signal-regulated kinase 2 or with a whole rat-brain extract. Seeding activity was measured using a FRET-based biosensor-cell method. We also used solution-state NMR to investigate the binding sites of CLR01 on tau and how they were impacted by phosphorylation. Our systematic structure-activity relationship study demonstrates that heparin-induced tau behaves differently from in-vitro phosphorylated tau. The aggregation rates of the different forms are distinct as is the intracellular localization of the induced aggregates, which resembles brain-derived tau strains suggesting that heparin-induced tau and in-vitro phosphorylated tau have different conformations, proper-ties, and activities. CLR01 inhibits aggregation and seeding of both heparin-induced and in-vitro-phosphorylated tau dose-dependently, although heparin induction interferes with the interaction between CLR01 and tau.


  • Open Access

    Two Tau binding sites on tubulin revealed by thiol-disulfide exchanges

    by Marlène Martinho, Diane Allegro, Isabelle Huvent, Charlotte Chabaud, Emilien Etienne, Hervé Kovacic, Bruno Guigliarelli, Vincent Peyrot, Isabelle Landrieu, Valérie Belle, et al.

    Tau is a Microtubule-associated protein that induces and stabilizes the formation of the Microtubule cytoskeleton and plays an important role in neurodegenerative diseases. The Microtubules binding region of Tau has been determined for a long time but where and how Tau binds to its partner still remain a topic of debate. We used Site Directed Spin Labeling combined with EPR spectroscopy to monitor Tau upon binding to either Taxol-stabilized MTs or to αβ-tubulin when Tau is directly used as an inducer of MTs formation. Using maleimide-functionalized labels grafted on the two natural cysteine residues of Tau, we found in both cases that Tau remains highly flexible in these regions confirming the fuzziness of Tau:MTs complexes. More interestingly, using labels linked by a disulfide bridge, we evidenced for the first time thiol disulfide exchanges between αβ-tubulin or MTs and Tau. Additionally, Tau fragments having the two natural cysteines or variants containing only one of them were used to determine the role of each cysteine individually. The difference observed in the label release kinetics between preformed MTs or Tau-induced MTs, associated to a comparison of structural data, led us to propose two putative binding sites of Tau on αβ-tubulin.


  • The Neuronal Tau Protein Blocks in Vitro Fibrillation of the Amyloid-β (Aβ) Peptide at the Oligomeric Stage

    by Cecilia Wallin, Yoshitaka Hiruma, Sebastian K. T. S. Wärmländer, Isabelle Huvent, Jüri Jarvet, Jan Pieter Abrahams, Astrid Gräslund, Guy Lippens, Jinghui Luo

    In Alzheimer’s disease, amyloid-β (Aβ) plaques and tau neurofibrillary tangles are the two pathological hallmarks. The co-occurrence and combined reciprocal pathological effects of Aβ and tau protein aggregation have been observed in animal models of the disease. However, the molecular mechanism of their interaction remain unknown. Using a variety of biophysical measurements, we here show that the native full-length tau protein solubilizes the Aβ40 peptide and prevents its fibrillation. The tau protein delays the amyloid fibrillation of the Aβ40 peptide at substoichiometric ratios, showing different binding affinities toward the different stages of the aggregated Aβ40 peptides. The Aβ monomer structure remains random coil in the presence of tau, as observed by nuclear magnetic resonance (NMR), circular dichroism (CD) spectroscopy and photoinduced cross-linking methods. We propose a potential interaction mechanism for the influence of tau on Aβ fibrillation.


  • Identification of the Tau phosphorylation pattern that drives its aggregation

    by Clément Despres, Cillian Byrne, Haoling Qi, François-Xavier Cantrelle, Isabelle Huvent, Béatrice Chambraud, Etienne-Emile Baulieu, Yves Jacquot, Isabelle Landrieu, Guy Lippens, et al.

    Significance: In Alzheimer’s disease, the microtubule-associated protein Tau is invariably found in a hyperphosphorylated and aggregated form. Whether (hyper)phosphorylation can drive aggregation is less clear, and no precise phosphorylation pattern leading to aggregation has been described. Combining in vitro phosphorylation assays with purified kinases and a rat brain extract with the analytical power of NMR spectroscopy, we unravel here the phosphorylation pattern of Tau that drives its aggregation. The results point to the importance of this posttranslational modification in Tau's aggregation and suggest orienting therapeutic strategies toward phosphorylated Tau.


  • Glycan Determinants of Heparin-Tau Interaction

    by Jing Zhao, Isabelle Huvent, Guy Lippens, David Eliezer, Anqiang Zhang, Quanhong Li, Peter Tessier, Robert J. Linhardt, Fuming Zhang, Chunyu Wang


  • Open Access

    Nuclear Magnetic Resonance Spectroscopy for the Identification of Multiple Phosphorylations of Intrinsically Disordered Proteins

    by Clément Danis, Clément Despres, Luiza M. Bessa, Idir Malki, Hamida Merzougui, Isabelle Huvent, Haoling Qi, Guy Lippens, François-Xavier Cantrelle, Robert Schneider, et al.

    We describe here a method to identify multiple phosphorylations of an intrinsically disordered protein by Nuclear Magnetic Resonance...


  • Open Access

    NMR Meets Tau: Insights into Its Function and Pathology

    by Guy Lippens, Isabelle Landrieu, Caroline Smet, Isabelle Huvent, Neha S. Gandhi, Benoît Gigant, Clément Despres, Haoling Qi, Juan Lopez

    In this review, we focus on what we have learned from Nuclear Magnetic Resonance (NMR) studies on the neuronal microtubule-associated protein Tau. We consider both the mechanistic details of Tau: the tubulin relationship and its aggregation process. Phosphorylation of Tau is intimately linked to both aspects. NMR spectroscopy has depicted accurate phosphorylation patterns by different kinases, and its non-destructive character has allowed functional assays with the same samples. Finally, we will discuss other post-translational modifications of Tau and its interaction with other cellular factors in relationship to its (dys)function.


  • Studying Intrinsically Disordered Proteins under True In Vivo Conditions by Combined Cross‐Polarization and Carbonyl‐Detection NMR Spectroscopy

    by Juan Lopez, Robert Schneider, Francois‐Xavier Cantrelle, Isabelle Huvent, Guy Lippens

    Under physiological conditions, studies of intrinsically disordered proteins (IDPs) by conventional NMR methods based on proton detection are severely limited by fast amide‐proton exchange with water. 13C detection has been proposed as a solution to the exchange problem, but is hampered by low sensitivity. We propose a new pulse sequence combining proton–nitrogen cross‐polarization and carbonyl detection to record high‐resolution, high‐sensitivity NMR spectra of IDPs under physiological conditions. To demonstrate the efficacy of this approach, we recorded a high‐quality N–CO correlation spectrum of α‐synuclein in bacterial cells at 37 °C.


  • Isomerization and Oligomerization of Truncated and Mutated Tau Forms by FKBP52 are Independent Processes

    by A. Kamah, F.X. Cantrelle, I. Huvent, J. Giustiniani, K. Guillemeau, C. Byrne, Y. Jacquot, I. Landrieu, E.E. Baulieu, C. Smet, et al.